Maltese MEP Cyrus Engerer has urged EU to look into the possibility of psychedelics such as MDMA and magic mushrooms, helping to treat mental health illnesses.
Speaking with Malta Daily, the PL MEP said “I’m urging the European Commission to invest in more research so that the European Union would be at the forefront of innovation in this field.”
Cyrus Engerer said, “Multiple trials, taking place in various parts of the world, are currently using MDMA, Psilocybin, N,N-Dimethyltryptamine (DMT) and Ketamine to treat PTSD, major depression disorder, alcohol abuse and anxiety disorders.”
The PL MEP explained that “Two of the most promising of these trials, one which seeks to treat PTSD with MDMA; and a second which seeks to treat treatment-resistant depression with Psilocybin, are in a phase three trial stage.”
The Maltese MEP stated that “The results coming out of those clinical trials show that psychedelic healthcare may possibly be the pill that finally helps us understand. The therapies are helping patients unlock parts of their psyche which stores trauma and suffering, and allows them to address those issues without the traditional feelings attached to assessing such trauma – such as fear and discomfort.”
#MaltaDaily